The TCGA analysis suggested that no molecular driver mutations are significantly associated with a “T cell-inflamed” tumor microenvironment, though data on EGFR mutated samples suggested a marginally significant increase in “T cell-inflamed” tumors (7% in “non-inflamed” versus 17% in “inflamed”). This evidence concerns the gene EGFR and neoplasm.